Status:
RECRUITING
Efficacy of a Phone-based Relapse Prevention for Anorexia Nervosa After a First Hospitalization
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
Anorexia Nervosa (AN) is a highly challenging disease which consequences are serious. Relapse rate is estimated between 38 and 41% during the year following hospitalization. The efficacy of patients' ...
Eligibility Criteria
Inclusion
- Subject over 15 years of age
- Diagnosis of AN (restrictive and/or purgative) according to DSM-5 criteria
- Included after a first inpatient hospitalization in specialized care
- Providing informed, dated and signed consent (for a minor, consent must be signed by both parents who have parental authority )
- With medical insurance
- Can be reached by telephone
Exclusion
- Uncompensated psychiatric pathology
- Refusal to participate in the study
- The inability to consent to care (patient or his/her legal representative)
- Pregnancy
- Major incapable subject or under guardianship or judicial protection
- Homelessness
- No mastery of reading and writing
Key Trial Info
Start Date :
March 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04102475
Start Date
March 18 2021
End Date
March 1 2026
Last Update
March 2 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Général
Hénin-Beaumont, France
2
Hôpital Fontan2, CHU
Lille, France
3
Hôpital Saint Vincent de Paul, GHICL
Lille, France
4
Cliniqie Lautreamont
Loos, France